Subscribe to these results:

Upcoming Workshops

For All Cancers

  1. May15
    Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips and Strategies to Find the Best Cancer Treatment and Health Care Team for You
    Tags:
    biomarkersblack or african americandoctor-patient communicationgenomicshealth care disparitiesside effectstreatment
    Register

Past workshops

For All Cancers

    1. Diverse Populations Participating in Decisions about Your Care with Your Health Care TeamPart II of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      black or african americanhealth care disparitieshealth care professionalslgbtq+treatmentdoctor-patient communication
    2. Understanding How Health Care Disparities May Influence Your Cancer Treatment and Care: With Tips & Strategies to Find the Best Cancer Treatment & Health Care Team for YouPart I of How Health Care Disparities May Influence Your Cancer Treatment and Care
      Tags:
      doctor-patient communicationhealth care disparitiesside effectstreatmentcoronavirusgenomicsbiomarkers
    3. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
      Tags:
      doctor-patient communication
    4. COVID-19, Omicron & Delta Variants, COVID-19 Vaccines & Booster Vaccines: Revised Guidelines for People Living with Cancer and Their Loved Ones
      Tags:
      coronavirusdoctor-patient communication
    5. How Health Care Disparities May Influence Your Cancer Treatment & Care
      Tags:
      doctor-patient communicationhealth care disparitiestreatmentblack or african american
    6. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
      Tags:
      doctor-patient communicationtreatment
    7. Cancer and Flu Shots
      Tags:
      adherencedoctor-patient communicationpost-treatment survivorshiptreatment
    8. Participating in Decisions about Your CarePart IV of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      caregivingcopingdoctor-patient communicationside effectscare planningtreatment
    9. Participating in Decisions about Your CarePart V of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      doctor-patient communicationtreatmentcare planning
    10. For Caregivers: Care Coordination for Your Loved One Living with Cancer and Other Health ProblemsPart IV of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      care planningcaregivingdoctor-patient communication
    11. Understanding the Costs of Care and Your Health Care CoveragePart III of Life with Cancer: A Guide to Getting the Best Care
      Tags:
      financial assistanceinsurancemedicarecare planningdoctor-patient communicationcoping
    12. Managing the Costs of Living with Cancer
      Tags:
      financial assistanceinsurancecopingdoctor-patient communication
    13. For Health Care Professionals: Care Coordination for Older Men Living with Cancer
      Tags:
      older adultsdoctor-patient communicationhealth care professionals
    14. Communicating with Your Health Care Team After Treatment: Making the Most of Your VisitPart II of The Eighth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
      Tags:
      post-treatment survivorshipdoctor-patient communicationadvocacy
    15. The Importance of Communicating with Your Doctor About Follow-Up CarePart I of The Sixth Annual Cancer Survivorship Series: Living With, Through and Beyond Cancer
      Tags:
      post-treatment survivorshipdoctor-patient communication

For Acute Lymphoblastic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Acute Myeloid Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Bladder Cancer

    1. Bladder Cancer: Treatment UpdatePart I of Life with Bladder Cancer
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments
    2. For Caregivers: Informative Tips to Cope with Your Loved One’s Bladder CancerPart II of Life with Bladder Cancer
      Tags:
      bladder cancercaregivingdoctor-patient communication
    3. Bladder Cancer: Treatment UpdatesPart I of Life with Bladder Cancer
      Tags:
      bladder cancertreatmentclinical trialsdiagnostic testsdoctor-patient communicationimmunotherapypersonalized medicinetargeted treatments

For Breast Cancer

    1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques
    2. Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart III of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancercaregivingdoctor-patient communicationholidaysstress
    3. Triple Negative Breast Cancer and Fear of RecurrencePart II of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancerrecurrencedoctor-patient communicationmind-bodystresscare planning

For Chronic Lymphocytic Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Chronic Myelogenous Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Cutaneous T-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Diffuse Large B-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Follicular Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Hodgkin Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Leukemia

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Lung Cancer

    1. Non-Small Cell Lung Cancer: For Caregivers – Practical Tips for CopingPart III of Living with Non-Small Cell Lung Cancer
      Tags:
      lung cancercaregivingcopingdoctor-patient communication
    2. Non-Small Cell Lung Cancer: What’s NewPart I of Living with Non-Small Cell Lung Cancer
      Tags:
      lung cancertreatmentcoronavirusdoctor-patient communicationside effects

For Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Mantle Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Marginal Zone Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Mesothelioma

    1. Mesothelioma: Innovative Treatment Options
      Tags:
      mesotheliomatreatmentchemotherapyimmunotherapypersonalized medicinetargeted treatmentsside effectsclinical trialsdoctor-patient communication

For Metastatic Breast Cancer

    1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques

For Multiple Myeloma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Coping with the Stresses of Caregiving When Your Loved One Has Multiple MyelomaPart II of Living with Multiple Myeloma
      Tags:
      multiple myelomacaregivingdoctor-patient communicationtreatment
    3. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication
    4. Progress in the Treatment of Multiple Myeloma
      Tags:
      multiple myelomatreatmentbone marrow transplantbone healthclinical trialsdoctor-patient communicationneuropathypainside effects

For Myelodysplastic Syndromes

    1. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Myeloproliferative Neoplasms

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Non-Hodgkin Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Peripheral T-Cell Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Small Lymphocytic Lymphoma

    1. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomaclinical trialsdoctor-patient communicationtreatment
    2. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
      Tags:
      acute lymphoblastic leukemiaacute myeloid leukemiachronic lymphocytic leukemiachronic myelogenous leukemiacutaneous t-cell lymphomadiffuse large b-cell lymphomafollicular lymphomahodgkin lymphomaleukemialymphomamantle cell lymphomamarginal zone lymphomamultiple myelomamyelodysplastic syndromesmyeloproliferative neoplasmsnon-hodgkin lymphomaperipheral t-cell lymphomasmall lymphocytic lymphomatreatmentclinical trialsdoctor-patient communication

For Triple Negative Breast Cancer

    1. Triple Negative Breast Cancer: Coping with the Fear of Recurrence
      Tags:
      breast cancermetastatic breast cancertriple negative breast canceranxietyrecurrencecare planningdoctor-patient communicationmind-bodystresscopingrelaxation techniques
    2. Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast CancerPart III of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancercaregivingdoctor-patient communicationholidaysstress
    3. Triple Negative Breast Cancer and Fear of RecurrencePart II of Living with Triple Negative Breast Cancer
      Tags:
      triple negative breast cancerbreast cancerrecurrencedoctor-patient communicationmind-bodystresscare planning
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.